Alzheimer’s disease Epidemiology Forecast to 2030

Alzheimer\'s disease Epidemiology Forecast to 2030

DelveInsight has launched a new report on Alzheimer’s disease Epidemiology Forecast to 2030

DelveInsight’s ‘Alzheimer’s disease (AD) – Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Alzheimer’s disease (AD) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

The Alzheimer’s disease (AD) market report provides current treatment practices, emerging drugs, Alzheimer’s disease (AD) market share of the individual therapies, current and forecasted Alzheimer’s disease (AD) market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Alzheimer’s disease (AD) treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.

Alzheimer’s disease is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills, and eventually the ability to carry out the simplest tasks. It is the most common cause of dementia (a continuous decline in thinking, behavioral and social skills that disrupts a person’s ability to function independently) accounting for ~60–80% of cases. The exact cause of Alzheimer’s disease is unknown, although a number of things are thought to increase your risk of developing the condition. These include increasing age, a family history of the condition, previous severe head injuries, and lifestyle factors and conditions associated with cardiovascular disease. The most common early symptom of Alzheimer’s is difficulty remembering newly learned information because Alzheimer’s changes typically begin in the part of the brain that affects learning.


Request for:- free sample page

Alzheimer’s disease (AD) Epidemiology Perspective by DelveInsight

The Alzheimer’s disease (AD) epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Alzheimer’s disease (AD) epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Alzheimer’s disease (AD) epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.


Alzheimer’s disease (AD) Detailed Epidemiology Segmentation

The Alzheimer’s disease (AD) epidemiology covered in the report provides historical as well as forecasted Alzheimer’s disease (AD) epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom) and Japan from 2017 to 2030.

The DelveInsight Alzheimer’s disease (AD) report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.


Scope of the Report

  • The Alzheimer’s disease (AD) report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The Alzheimer’s disease (AD) Epidemiology Report and Model provide an overview of the risk factors and global trends of Alzheimer’s disease (AD) in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight about the historical and forecasted patient pool of Alzheimer’s disease (AD) in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Alzheimer’s disease (AD)
  • The report provides the segmentation of the Alzheimer’s disease (AD) epidemiology


Report Highlights

  • 11-Year Forecast of Alzheimer’s disease (AD) epidemiology
  • 7MM Coverage
  • Total Cases of Alzheimer’s disease (AD)
  • Total Cases of Alzheimer’s disease (AD) according to segmentation
  • Diagnosed cases of Alzheimer’s disease (AD)

Key companies are working on this disease that are given below:-  

1. Lohmann Therapie- Systeme/ Novartis Pharma Co.
2. Green Valley Pharmaceuticals.
3. AgeneBio

Name of drugs covered are given below:-

1. Exelon
3. AGB101

Table of contents

1. Key Insights 

2. Executive Summary of Alzheimer’s disease (AD)

3. Alzheimer’s disease (AD): Disease Background and Overview

4. Patient Journey

5. Epidemiology and Patient Population

6. Treatment Algorithm, Current Treatment, and Medical Practices

6.1. Alzheimer’s disease (AD) Treatment and Management

6.2. Alzheimer’s disease (AD) Treatment Algorithm

7. KOL Views

8. Unmet Needs

9.  Appendix

9.1. Bibliography

9.2. Report Methodology

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

Why should you buy this report?

  • The Alzheimer’s disease (AD) Epidemiology report will allow the user to –
  • Develop business strategies by understanding the trends shaping and driving the global Alzheimer’s disease (AD) market
  • Quantify patient populations in the global Alzheimer’s disease (AD) market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Alzheimer’s disease (AD) therapeutics in each of the markets covered
  • Understand the magnitude of Alzheimer’s disease (AD) population by its epidemiology
  • The Alzheimer’s disease (AD) Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

Related Reports:- 

1. Alzheimer’s disease (AD)- Market Insight, Epidemiology and Market Forecast -2030

2. Alzheimer’s disease (AD) – Epidemiology Forecast to 2030

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States